Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers.
PSMA PET
bone scans
initial staging
oncology
prostate cancer
radiopharmaceuticals
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
21
04
2023
revised:
05
07
2023
medline:
6
11
2023
pubmed:
18
8
2023
entrez:
17
8
2023
Statut:
ppublish
Résumé
Prostate-specific membrane antigen (PSMA) PET has a higher accuracy than CT and bone scans to stage patients with prostate cancer. We do not understand how to apply clinical trial data based on conventional imaging to patients staged using PSMA PET. Therefore, we aimed to evaluate the ability of bone scans to detect osseous metastases using PSMA PET as a reference standard.
Identifiants
pubmed: 37591547
pii: jnumed.123.265916
doi: 10.2967/jnumed.123.265916
doi:
Substances chimiques
Gallium Radioisotopes
0
Types de publication
Multicenter Study
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1744-1747Subventions
Organisme : NCI NIH HHS
ID : R01 CA235741
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA212148
Pays : United States
Informations de copyright
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.